References
- NavariRMEinhornLHPassikSDA phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier Oncology Group studySupport Care Cancer200513752953415700131
- NavariRMEinhornLHLoehrerPJA phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier Oncology Group studySupport Care Cancer20071511128517375339
- AbeMHirashimaYKasamatsuYEfficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy in gynecological cancer: KCOG-G1301 phase II trialSupport Care Cancer201624267568226130365
- MaedaAUraTAsanoCA phase II trial of prophylactic olanzapine combined with palonosetron and dexamethasone for preventing nausea and vomiting induced by cisplatinAsia Pac J Clin Oncol201612325425827030364
- NakashimaKMurakamiHYokoyamaKA phase II study of palonosetron, aprepitant, dexamethasone and olanzapine for the prevention of cisplatin-based chemotherapy-induced nausea and vomiting in patients with thoracic malignancyJpn J Clin Oncol201747984084328633504
- YanaiTIwasaSHashimotoHA double-blind randomized phase II dose-finding study of olanzapine 10 mg or 5 mg for the prophylaxis of emesis induced by highly emetogenic cisplatin-based chemotherapyInt J Clin Oncol201823238238829039073
- SaitoMAogiKSekineIPalonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trialLancet Oncol200910211512419135415
- NavariRMGraySEKerrACOlanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a randomized phase III trialJ Support Oncol20119518819522024310
- ChowRChiuLNavariREfficacy and safety of olanzapine for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) as reported in phase I and II studies: a systematic reviewSupport Care Cancer20162421001100826530228
- ChelkebaLGideyKMamoAYohannesBMatsoTMelakuTOlanzapine for chemotherapy-induced nausea and vomiting: systematic review and meta-analysisPharm Pract2017151877
- SuzukiMKomuroKOharaKOlanzapine and betamethasone are effective for the treatment of nausea and vomiting due to metastatic brain tumors of rectal cancerCase Rep Gastroenterol201481131724574944
- KaneishiKKawabataMMoritaTOlanzapine for the relief of nausea in patients with advanced cancer and incomplete bowel obstructionJ Pain Symptom Manage201244460460722771132
- KaneishiKNishimuraKSakuraiNUse of olanzapine for the relief of nausea and vomiting in patients with advanced cancer: a multicenter survey in JapanSupport Care Cancer20162462393239526838020
- MackintoshDOlanzapine in the management of difficult to control nausea and vomiting in a palliative care population: a case seriesJ Palliat Med2016191879026398872
- NavariRMBrennerMCTreatment of cancer-related anorexia with olanzapine and megestrol acetate: a randomized trialSupport Care Cancer201018895195619756773
- NaingADalalSAbdelrahimMOlanzapine for cachexia in patients with advanced cancer: an exploratory study of effects on weight and metabolic cytokinesSupport Care Cancer20152392649265425680763
- LeggeroCMasiGBrunoriELow-dose olanzapine monotherapy in girls with anorexia nervosa, restricting subtype: focus on hyperactivityJ Child Adolesc Psychopharmacol201020212713320415608
- PassikSDLundbergJKirshKLA pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and painJ Pain Symptom Manage200223652653212067777